Hosted by Horizon 3 Biotech Chief Investment Officer Matt McNamara. In this episode, Matt is joined by Dr Michelle Miller -  CEO and MD at Biotron Limited &amp; Scott Power - Investment Analyst at Morgans &amp; Horizon 3 Biotech Investment Community Member.

Hosted by Horizon 3 Biotech Chief Investment Officer Matt McNamara. In this episode, Matt is joined by Dr Michelle Miller -  CEO and MD at Biotron Limited &amp; Scott Power - Investment Analyst at Morgans &amp; Horizon 3 Biotech Investment Community Member.

Investing in Biotech

Hosted by Horizon 3 Biotech Chief Investment Committee Member Dr Tam Nguyen. In this episode, Tam is joined by Dr Serena Duchi - Senior Research Fellow. Surgery at St Vincent's Hospital &amp; Dr Ross MacDonald - Chief Executive Officer and Managing Director at Cynata Therapeutics.

Hosted by Horizon 3 Biotech Chief Investment Committee Member Dr Tam Nguyen. In this episode, Tam is joined by Dr Serena Duchi - Senior Research Fellow. Surgery at St Vincent's Hospital &amp; Dr Ross MacDonald - Chief Executive Officer and Managing Director at Cynata Therapeutics.

Hosted by Horizon 3 Biotech Chief Investment Committee Member Dr Tam Nguyen. In this episode, Tam is joined by Michelle Gallaher -  Founder &amp; CEO at Opyl Ltd  &amp; Stefan Harrer - Chief Innovation Officer at Digital Health CRC Ltd.

Hosted by Horizon 3 Biotech Chief Investment Committee Member Dr Tam Nguyen. In this episode, Tam is joined by Michelle Gallaher -  Founder &amp; CEO at Opyl Ltd  &amp; Stefan Harrer - Chief Innovation Officer at Digital Health CRC Ltd.

Hosted by Horizon 3 Biotech Chief Investment Officer Matt McNamara. In this episode, Matt is joined by Jackie Fairley -  CEO at Starpharmas &amp; Scott Power - Investment Analyst at Morgans &amp; Horizon 3 Biotech Investment Community Member.

Hosted by Horizon 3 Biotech Chief Investment Officer Matt McNamara. In this episode, Matt is joined by Jackie Fairley -  CEO at Starpharmas &amp; Scott Power - Investment Analyst at Morgans &amp; Horizon 3 Biotech Investment Community Member.

Hosted by Horizon 3 Biotech Chief Investment Officer Matt McNamara. In this episode, Matt is joined by John McCutcheon - President &amp; CEO at President and CEO at EBR Systems &amp; Elyse Shapiro - Healthcare Analyst at from Canaccord Genuity.

Hosted by Horizon 3 Biotech Chief Investment Officer Matt McNamara. In this episode, Matt is joined by John McCutcheon - President &amp; CEO at President and CEO at EBR Systems &amp; Elyse Shapiro - Healthcare Analyst at from Canaccord Genuity.

Hosted by Horizon 3 Biotech Chief Investment Officer Matt McNamara. In this episode, Matt is joined by Dr Megan Baldwi - CEO and Managing Director at Opthea Limited &amp; Daniel Sharp from Canaccord Genuity, one of the most experienced biotech fundraisers in the Australian Market.

Hosted by Horizon 3 Biotech Chief Investment Officer Matt McNamara. In this episode, Matt is joined by Dr Megan Baldwi - CEO and Managing Director at Opthea Limited &amp; Daniel Sharp from Canaccord Genuity, one of the most experienced biotech fundraisers in the Australian Market.

Hosted by Horizon 3 Biotech Chief Investment Officer Matt McNamara. In this episode Matt is joined by Amir Zalcenstein - Managing Director at CNJ Ventures &amp; Leslie Chong - Chief Executive Officer and Managing Director at Imugene Limited.

Hosted by Horizon 3 Biotech Chief Investment Officer Matt McNamara. In this episode Matt is joined by Amir Zalcenstein - Managing Director at CNJ Ventures &amp; Leslie Chong - Chief Executive Officer and Managing Director at Imugene Limited.

Mike and Ben talk about Scott Galloway's theory of the Great Dispersion - the impact of COVID on business models like direct-to-consumer and how far they're spreading

Mike and Ben talk about Scott Galloway's theory of the Great Dispersion - the impact of COVID on business models like direct-to-consumer and how far they're spreading

BioBullets: The Great Dispersion

Hosted by Horizon 3 Biotech Chief Investment Officer Matt McNamara. In this episode Matt is joined by Michael Woods of Newburyport Partners, Dr John Melki Director &amp; CEO at Genetic Signatures &amp; Dr Paul Gavin - CEO of Avecho Biotechnologies.

Hosted by Horizon 3 Biotech Chief Investment Officer Matt McNamara. In this episode Matt is joined by Michael Woods of Newburyport Partners, Dr John Melki Director &amp; CEO at Genetic Signatures &amp; Dr Paul Gavin - CEO of Avecho Biotechnologies.

Hosted by Horizon 3 Biotech Chief Investment Officer Matt McNamara In this episode Matt will be joined by Scott Power of Morgans and Jon Pilcher, CEO of Neuren Pharmaceuticals.

Hosted by Horizon 3 Biotech Chief Investment Officer Matt McNamara In this episode Matt will be joined by Scott Power of Morgans and Jon Pilcher, CEO of Neuren Pharmaceuticals.

Horizon 3 is a biotech fund which has been formed to help investors to have a real impact on a range of global health challenges through new bio technologies, aiming to de-risk the investment risks inherent in such a technical area.These podcasts are a series aimed at educating investors on the issues, risks and opportunities involved in investing ion the biotech sector.

This podcast accompanies Horizon 3 Biotech's BioBullets email for the 13th August 2021

This podcast accompanies Horizon 3 Biotech's BioBullets email for the 13th August 2021

BioBullets: The Aduhelm FDA approval controversy 

Hosted by Horizon 3 Biotech Chief Investment Officer Matt McNamara In this episode Matt will be joined by Dirk van Dissel of Candour Advisory and Chris Baldwin, Deputy CEO and Chief Commercial Officer of Exopharm.

Hosted by Horizon 3 Biotech Chief Investment Officer Matt McNamara In this episode Matt will be joined by Dirk van Dissel of Candour Advisory and Chris Baldwin, Deputy CEO and Chief Commercial Officer of Exopharm.

Hosted by Horizon 3 Biotech Chief Investment Officer Matt McNamara In this episode Matt will be joined by Dr Deborah Rathjen, CEO of Carina Biotech and Simon Davidson, Partner at Lander &amp; Rogers

Hosted by Horizon 3 Biotech Chief Investment Officer Matt McNamara In this episode Matt will be joined by Dr Deborah Rathjen, CEO of Carina Biotech and Simon Davidson, Partner at Lander &amp; Rogers

Hosted by Horizon 3 Biotech Chief Investment Officer Matt McNamara In this episode Matt will be joined by Rosemary Cummins of NXT Financial and Ralph Highnam of Volpara Health Technologies.

Hosted by Horizon 3 Biotech Chief Investment Officer Matt McNamara In this episode Matt will be joined by Rosemary Cummins of NXT Financial and Ralph Highnam of Volpara Health Technologies.

A chance to meet with Mike, Horizon 3's Executive Chairman, and Matt, the Chief Investment Officer, as they talk about Horizon 3's origins, who its right for and what makes the fund distinctive.

A chance to meet with Mike, Horizon 3's Executive Chairman, and Matt, the Chief Investment Officer, as they talk about Horizon 3's origins, who its right for and what makes the fund distinctive.

Introduction to Horizon 3

Hosted by Horizon 3 Biotech Chief Investment Officer Matt McNamara. In this episode Matt will be joined by Tony Locantro from Alto Capital and Sue MacLeman who serves in a number of roles with various organisations and companies. 

Hosted by Horizon 3 Biotech Chief Investment Officer Matt McNamara. In this episode Matt will be joined by Tony Locantro from Alto Capital and Sue MacLeman who serves in a number of roles with various organisations and companies.

Hosted by Horizon 3 Biotech Chief Investment Officer Matt McNamara. Matt MacNamara, Chief Investment Officer at Horizon 3 Biotech &amp;  Scott Power, Investment Committee at Horizon 3 Biotech.

Hosted by Horizon 3 Biotech Chief Investment Officer Matt McNamara. Matt MacNamara, Chief Investment Officer at Horizon 3 Biotech &amp;  Scott Power, Investment Committee at Horizon 3 Biotech.

Hosted by Horizon 3 Biotech Chief Investment Officer Matt McNamara. In this episode Matt will be joined by Horizon 3 Biotech Life Sciences and Capital Markets Executive Dr Graeme Wald and Investment Analyst Scott Power who will be sharing topical investment strategies.

Hosted by Horizon 3 Biotech Chief Investment Officer Matt McNamara. In this episode Matt will be joined by Horizon 3 Biotech Life Sciences and Capital Markets Executive Dr Graeme Wald and Investment Analyst Scott Power who will be sharing topical investment strategies.

Topical investment strategies in biotech

Hosted by Horizon 3 Biotech Chief Investment Officer Matt McNamara. Matt &amp; Scott Power speak to Dr Nina Webster from Dimerix and CEO &amp; MD Dr Matthijs Smith of Crucible Investments.

Hosted by Horizon 3 Biotech Chief Investment Officer Matt McNamara. Matt &amp; Scott Power speak to Dr Nina Webster from Dimerix and CEO &amp; MD Dr Matthijs Smith of Crucible Investments.

Matt talks to Dimerix & Crucible Investments

Hosted by Horizon 3 Biotech Chief Investment Officer Matt McNamara. Matt &amp; Scott Power, Investment Committee at Horizon 3 Biotech, discuss the origins of the Horizon 3 fund, what drives investment decisions and some of Scott's recommendations for investment in the coming months

Hosted by Horizon 3 Biotech Chief Investment Officer Matt McNamara. Matt &amp; Scott Power, Investment Committee at Horizon 3 Biotech, discuss the origins of the Horizon 3 fund, what drives investment decisions and some of Scott's recommendations for investment in the coming months

Horizon 3 Biotech Fund and what drives investment decisions

Investing in Biotech from Horizon 3 Biotech

The best podcast episodes on global issues affecting everyone. Covering topics such as the #metoo movement, climate change, the impact of technology and some of the biggest global issues facing us right now. For anyone interested in learning more about the world, and some of the issues we're facing, pick an episode below and start listening! Add episodes you're interested into your queue below!

Best Episodes on Global Issues

The best episodes for anyone looking to learn more about topics such as happiness, fulfillment, depression and psychology/mental health in general. With interviews with industry experts, personal stories of individuals, this topic has lessons applicable to everyone. Add episodes you're interested into your queue below!